3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase NA
2
Phase 4
2
Phase 3
2
Phase EARLY_PHASE1
1
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
158
OTHER
48
NIH
7
OTHER_GOV
2
UNKNOWN
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
2
Interventions
Radiotherapy
10
Cisplatin
10
Carboplatin
7
Capecitabine
6
Neoadjuvant Therapy
5
Gemcitabine
5
Fluorouracil
5
Docetaxel
5
Paclitaxel
4
Cyclophosphamide
4
Trastuzumab
3
Tamoxifen
3
Surgical Procedures, Operative
3
Radiation
3
Oxaliplatin
3
Hydralazine
3
Etoposide
3
Drug Therapy
3
pertuzumab
2
pegylated granulocyte colony-stimulating factor
2
palbociclib
2
endostar protein
2
Valproic Acid
2
Tranexamic Acid
2
Temozolomide
2
TP protocol
2
Saline Solution
2
Radiotherapy, Adjuvant
2
Proton Pump Inhibitors
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER_GOV
×
Pemetrexed
×
Clear all
NCT07050043
2025-07-03
LEDANG
Hospital Sultanah Bahiyah
Phase 3
Recruiting
123 enrolled
NCT01836575
2013-04-22
PS2
Instituto Nacional de Cancer, Brazil
Phase 3
Completed
228 enrolled